Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 316

1.

Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial.

Hayashida T, Jinno H, Mori K, Sato H, Matsui A, Sakurai T, Hattori H, Takayama S, Wada M, Takahashi M, Seki H, Seki T, Nagayama A, Matsumoto A, Kitagawa Y.

BMC Cancer. 2018 Jun 28;18(1):701. doi: 10.1186/s12885-018-4628-7.

2.

Bilateral cerebellar cysts and cerebral white matter lesions with cortical dysgenesis: Expanding the phenotype of LAMB1 gene mutations.

Okazaki T, Saito Y, Hayashida T, Akaboshi S, Miyake N, Matsumoto N, Kasagi N, Adachi K, Shinohara Y, Nanba E, Maegaki Y.

Clin Genet. 2018 Jun 10. doi: 10.1111/cge.13378. [Epub ahead of print]

PMID:
29888467
3.

Antitumor effect of lapatinib and cytotoxic agents by suppression of E2F1 in HER2‑positive breast cancer.

Matsumoto A, Hayashida T, Takahashi M, Jinno H, Kitagawa Y.

Mol Med Rep. 2018 Jul;18(1):958-964. doi: 10.3892/mmr.2018.9068. Epub 2018 May 23.

PMID:
29845287
4.

Clinicopathologic features of hormone-receptor-positive breast cancer patients with late recurrence.

Murata T, Jinno H, Takahashi M, Shimoda M, Hayashida T, Kameyama K, Kitagawa Y.

Breast J. 2018 Apr 23. doi: 10.1111/tbj.13033. [Epub ahead of print]

PMID:
29687661
5.

Further characterization of CAPOS/CAOS syndrome with the Glu818Lys mutation in the ATP1A3 gene: A case report.

Hayashida T, Saito Y, Ishii A, Hirose S, Hiraiwa R, Maegaki Y, Ohno K.

Brain Dev. 2018 Aug;40(7):576-581. doi: 10.1016/j.braindev.2018.03.004. Epub 2018 Apr 3.

PMID:
29625811
6.

Hybrid Sterility in Fish Caused by Mitotic Arrest of Primordial Germ Cells.

Yoshikawa H, Xu D, Ino Y, Yoshino T, Hayashida T, Wang J, Yazawa R, Yoshizaki G, Takeuchi Y.

Genetics. 2018 Jun;209(2):507-521. doi: 10.1534/genetics.118.300777. Epub 2018 Apr 2.

PMID:
29610216
7.

The second molecular epidemiological study of HIV infection in Mongolia between 2010 and 2016.

Jagdagsuren D, Hayashida T, Takano M, Gombo E, Zayasaikhan S, Kanayama N, Tsuchiya K, Oka S.

PLoS One. 2017 Dec 15;12(12):e0189605. doi: 10.1371/journal.pone.0189605. eCollection 2017.

8.

Comprehensive genomic sequencing detects important genetic differences between right-sided and left-sided colorectal cancer.

Shimada Y, Kameyama H, Nagahashi M, Ichikawa H, Muneoka Y, Yagi R, Tajima Y, Okamura T, Nakano M, Sakata J, Kobayashi T, Nogami H, Maruyama S, Takii Y, Hayashida T, Takaishi H, Kitagawa Y, Oki E, Konishi T, Ishida F, Kudo SE, Ring JE, Protopopov A, Lyle S, Ling Y, Okuda S, Ishikawa T, Akazawa K, Takabe K, Wakai T.

Oncotarget. 2017 Aug 24;8(55):93567-93579. doi: 10.18632/oncotarget.20510. eCollection 2017 Nov 7.

9.

The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer.

Nakashoji A, Hayashida T, Yokoe T, Maeda H, Toyota T, Kikuchi M, Watanuki R, Nagayama A, Seki T, Takahashi M, Abe T, Kitagawa Y.

Cancer Treat Rev. 2018 Jan;62:9-17. doi: 10.1016/j.ctrv.2017.10.009. Epub 2017 Oct 31. Review.

PMID:
29127857
10.

Development and characterization of a strawberry MAGIC population derived from crosses with six strawberry cultivars.

Wada T, Oku K, Nagano S, Isobe S, Suzuki H, Mori M, Takata K, Hirata C, Shimomura K, Tsubone M, Katayama T, Hirashima K, Uchimura Y, Ikegami H, Sueyoshi T, Obu KI, Hayashida T, Shibato Y.

Breed Sci. 2017 Sep;67(4):370-381. doi: 10.1270/jsbbs.17009. Epub 2017 Aug 4.

11.

Self-rated cognitive functions following chemotherapy in patients with breast cancer: a 6-month prospective study.

Kitahata R, Nakajima S, Uchida H, Hayashida T, Takahashi M, Nio S, Hirano J, Nagaoka M, Suzuki T, Jinno H, Kitagawa Y, Mimura M.

Neuropsychiatr Dis Treat. 2017 Oct 3;13:2489-2496. doi: 10.2147/NDT.S141408. eCollection 2017.

12.

Downregulation of cytochrome c oxidase 1 induced radioresistance in esophageal squamous cell carcinoma.

Takesue T, Kawakubo H, Hayashida T, Tsutsui M, Miyao K, Fukuda K, Nakamura R, Takahashi T, Wada N, Takeuchi H, Kitagawa Y.

Oncol Lett. 2017 Oct;14(4):4220-4224. doi: 10.3892/ol.2017.6699. Epub 2017 Aug 1.

13.

CACNA1A-related early-onset encephalopathy with myoclonic epilepsy: A case report.

Hayashida T, Saito Y, Ishii A, Yamada H, Itakura A, Minato T, Fukuyama T, Maegaki Y, Hirose S.

Brain Dev. 2018 Feb;40(2):130-133. doi: 10.1016/j.braindev.2017.08.006. Epub 2017 Sep 18.

PMID:
28927557
14.

PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection.

Shimada T, Nagata N, Okahara K, Joya A, Hayashida T, Oka S, Sakurai T, Akiyama J, Uemura N, Gatanaga H.

PLoS One. 2017 Sep 13;12(9):e0184699. doi: 10.1371/journal.pone.0184699. eCollection 2017.

15.

Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis.

Okahara K, Nagata N, Shimada T, Joya A, Hayashida T, Gatanaga H, Oka S, Sakurai T, Uemura N, Akiyama J.

PLoS One. 2017 Sep 8;12(9):e0183951. doi: 10.1371/journal.pone.0183951. eCollection 2017.

16.

High plasma concentrations of dolutegravir in patients with ABCG2 genetic variants.

Tsuchiya K, Hayashida T, Hamada A, Oki S, Oka S, Gatanaga H.

Pharmacogenet Genomics. 2017 Nov;27(11):416-419. doi: 10.1097/FPC.0000000000000308.

PMID:
28858994
17.

Appropriate indices for color rendition and their recommended values for UHDTV production using white LED lighting.

Hayashida T, Iwasaki H, Masaoka K, Shimizu M, Yamashita T, Iwai W.

Opt Express. 2017 Jun 26;25(13):15010-15027. doi: 10.1364/OE.25.015010.

PMID:
28788936
18.

Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection.

Gatanaga H, Brumme ZL, Adland E, Reyes-Terán G, Avila-Rios S, Mejía-Villatoro CR, Hayashida T, Chikata T, Van Tran G, Van Nguyen K, Meza RI, Palou EY, Valenzuela-Ponce H, Pascale JM, Porras-Cortés G, Manzanero M, Lee GQ, Martin JN, Carrington MN, John M, Mallal S, Poon AFY, Goulder P, Takiguchi M, Oka S; International HIV Adaptation Collaborative.

AIDS. 2017 Sep 10;31(14):1935-1943. doi: 10.1097/QAD.0000000000001575.

PMID:
28650381
19.

Current situations and discussions in Japan in relation to the new occupational equivalent dose limit for the lens of the eye.

Yokoyama S, Hamada N, Hayashida T, Tsujimura N, Tatsuzaki H, Kurosawa T, Nabatame K, Ohguchi H, Ohno K, Yamauchi-Kawaura C, Iimoto T, Ichiji T, Hotta Y, Iwai S, Akahane K.

J Radiol Prot. 2017 Sep 25;37(3):659-683. doi: 10.1088/1361-6498/aa73e8. Epub 2017 May 18.

PMID:
28516892
20.

Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressors.

Hayashida T, Tsuchiya K, Kikuchi Y, Oka S, Gatanaga H.

PLoS One. 2017 May 4;12(5):e0177033. doi: 10.1371/journal.pone.0177033. eCollection 2017.

21.

The use of laparoscopic rectopexy to manage rectal prolapse with Pseudo-Meigs' syndrome in a 64-year-old female: a case report.

Kondo T, Tsuruta M, Hasegawa H, Okabayashi K, Shigeta K, Hayashida T, Kitagawa Y.

Clin Case Rep. 2017 Mar 29;5(5):642-644. doi: 10.1002/ccr3.918. eCollection 2017 May.

22.

Establishment of intraperitoneal germ cell transplantation for critically endangered Chinese sturgeon Acipenser sinensis.

Ye H, Li CJ, Yue HM, Du H, Yang XG, Yoshino T, Hayashida T, Takeuchi Y, Wei QW.

Theriogenology. 2017 May;94:37-47. doi: 10.1016/j.theriogenology.2017.02.009. Epub 2017 Feb 13.

PMID:
28407859
23.

Quantification of DNA fragmentation in processed foods using real-time PCR.

Mano J, Nishitsuji Y, Kikuchi Y, Fukudome SI, Hayashida T, Kawakami H, Kurimoto Y, Noguchi A, Kondo K, Teshima R, Takabatake R, Kitta K.

Food Chem. 2017 Jul 1;226:149-155. doi: 10.1016/j.foodchem.2017.01.064. Epub 2017 Jan 16.

PMID:
28254006
24.

Valgus Slipped Capital Femoral Epiphysis in Patient with Hypopituitarism.

Kotoura Y, Fujiwara Y, Hayashida T, Murakami K, Makio S, Shimizu Y, Oka Y, Kim WC, Ogura T, Kubo T.

Case Rep Orthop. 2017;2017:8981250. doi: 10.1155/2017/8981250. Epub 2017 Jan 5.

25.

Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3.

Baumann B, Hayashida T, Liang X, Schnaper HW.

Kidney Int. 2016 Oct;90(4):797-808. doi: 10.1016/j.kint.2016.05.026. Epub 2016 Aug 5.

26.

Nonvortical Rashba Spin Structure on a Surface with C_{1h} Symmetry.

Annese E, Kuzumaki T, Müller B, Yamamoto Y, Nakano H, Kato H, Araki A, Ohtaka M, Aoki T, Ishikawa H, Hayashida T, Osiecki JR, Miyamoto K, Takeichi Y, Harasawa A, Yaji K, Shirasawa T, Nittoh K, Yang W, Miki K, Oda T, Yeom HW, Sakamoto K.

Phys Rev Lett. 2016 Jul 1;117(1):016803. doi: 10.1103/PhysRevLett.117.016803. Epub 2016 Jun 30.

PMID:
27419582
27.

A randomized controlled study comparing a vessel sealing system with the conventional technique in axillary lymph node dissection for primary breast cancer.

Seki T, Hayashida T, Takahashi M, Jinno H, Kitagawa Y.

Springerplus. 2016 Jul 7;5(1):1004. doi: 10.1186/s40064-016-2710-7. eCollection 2016.

28.

Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations.

Hayashida T, Hachiya A, Ode H, Nishijima T, Tsuchiya K, Sugiura W, Takiguchi M, Oka S, Gatanaga H.

J Antimicrob Chemother. 2016 Oct;71(10):2760-6. doi: 10.1093/jac/dkw224. Epub 2016 Jun 20.

PMID:
27330069
29.

Prevention of neurological complications using a neural monitoring system with a finger electrode in the extreme lateral interbody fusion approach.

Narita W, Takatori R, Arai Y, Nagae M, Tonomura H, Hayashida T, Ogura T, Fujiwara H, Kubo T.

J Neurosurg Spine. 2016 Oct;25(4):456-463. Epub 2016 May 20.

PMID:
27203809
30.

Anti-TGF-β Antibody, 1D11, Ameliorates Glomerular Fibrosis in Mouse Models after the Onset of Proteinuria.

Liang X, Schnaper HW, Matsusaka T, Pastan I, Ledbetter S, Hayashida T.

PLoS One. 2016 May 17;11(5):e0155534. doi: 10.1371/journal.pone.0155534. eCollection 2016.

31.

Brief Report: High Peak Level of Plasma Raltegravir Concentration in Patients With ABCB1 and ABCG2 Genetic Variants.

Tsuchiya K, Hayashida T, Hamada A, Oka S, Gatanaga H.

J Acquir Immune Defic Syndr. 2016 May 1;72(1):11-4. doi: 10.1097/QAI.0000000000000893.

PMID:
27097364
32.

Atomic Force Microscopy of DNA-wrapped Single-walled Carbon Nanotubes in Aqueous Solution.

Hayashida T, Umemura K.

Colloids Surf B Biointerfaces. 2016 Jul 1;143:526-531. doi: 10.1016/j.colsurfb.2016.03.068. Epub 2016 Mar 24.

PMID:
27045980
33.

Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study.

Nishijima T, Hayashida T, Kurosawa T, Tanaka N, Oka S, Gatanaga H.

PLoS One. 2015 Nov 4;10(11):e0141931. doi: 10.1371/journal.pone.0141931. eCollection 2015.

34.

Biological markers of invasive breast cancer.

Matsumoto A, Jinno H, Ando T, Fujii T, Nakamura T, Saito J, Takahashi M, Hayashida T, Kitagawa Y.

Jpn J Clin Oncol. 2016 Feb;46(2):99-105. doi: 10.1093/jjco/hyv153. Epub 2015 Oct 20. Review.

PMID:
26486826
35.

Corrigendum: Dimethylaminopyridine-Supported Graft Polymer Catalyst and its Flow System.

Okuno Y, Isomura S, Kamakura T, Sano F, Tamahori K, Goto T, Hayashida T, Kitagawa Y, Fukuhara A, Takeda K.

ChemSusChem. 2015 Sep 7;8(17):2764. doi: 10.1002/cssc.201501065. Epub 2015 Aug 18. No abstract available.

PMID:
26334770
36.

Technical feasibility of sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence and previous axillary surgery.

Matsumoto A, Jinno H, Nakamura T, Saito J, Takahashi M, Hayashida T, Kameyama K, Kitagawa Y.

Int J Surg. 2015 Oct;22:28-31. doi: 10.1016/j.ijsu.2015.07.709. Epub 2015 Aug 13.

37.

Comparison of oncological safety between nipple sparing mastectomy and total mastectomy using propensity score matching.

Seki T, Jinno H, Okabayashi K, Murata T, Matsumoto A, Takahashi M, Hayashida T, Kitagawa Y.

Ann R Coll Surg Engl. 2015 May;97(4):291-7. doi: 10.1308/003588415X14181254788881.

38.

Comprehensive screening of genes resistant to an anticancer drug in esophageal squamous cell carcinoma.

Tsutsui M, Kawakubo H, Hayashida T, Fukuda K, Nakamura R, Takahashi T, Wada N, Saikawa Y, Omori T, Takeuchi H, Kitagawa Y.

Int J Oncol. 2015 Sep;47(3):867-74. doi: 10.3892/ijo.2015.3085. Epub 2015 Jul 16.

39.

Kaurenoic Acid Possesses Leishmanicidal Activity by Triggering a NLRP12/IL-1β/cNOS/NO Pathway.

Miranda MM, Panis C, da Silva SS, Macri JA, Kawakami NY, Hayashida TH, Madeira TB, Acquaro VR Jr, Nixdorf SL, Pizzatti L, Ambrósio SR, Cecchini R, Arakawa NS, Verri WA Jr, Costa IC, Pavanelli WR.

Mediators Inflamm. 2015;2015:392918. doi: 10.1155/2015/392918. Epub 2015 May 13.

40.

Dimethylaminopyridine-supported graft polymer catalyst and its flow system.

Okuno Y, Isomura S, Kamakura T, Sano F, Tamahori K, Goto T, Hayashida T, Kitagawa Y, Fukuhara A, Takeda K.

ChemSusChem. 2015 May 22;8(10):1711-5. doi: 10.1002/cssc.201500092. Epub 2015 Apr 8. Erratum in: ChemSusChem. 2015 Sep 7;8(17):2764.

PMID:
25855359
41.

Response.

Nagayama A, Hayashida T, Jinno H, Takahashi M, Kitagawa Y.

J Natl Cancer Inst. 2015 Mar 3;107(4). pii: djv039. doi: 10.1093/jnci/djv039. Print 2015 Apr. No abstract available.

PMID:
25739418
42.

Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure model.

Tanaka M, Shinoda M, Takayanagi A, Oshima G, Nishiyama R, Fukuda K, Yagi H, Hayashida T, Masugi Y, Suda K, Yamada S, Miyasho T, Hibi T, Abe Y, Kitago M, Obara H, Itano O, Takeuchi H, Sakamoto M, Tanabe M, Maruyama I, Kitagawa Y.

J Surg Res. 2015 Apr;194(2):571-80. doi: 10.1016/j.jss.2014.11.022. Epub 2014 Nov 22.

PMID:
25498512
43.

Pimaradienoic acid inhibits inflammatory pain: inhibition of NF-κB activation and cytokine production and activation of the NO-cyclic GMP-protein kinase G-ATP-sensitive potassium channel signaling pathway.

Possebon MI, Mizokami SS, Carvalho TT, Zarpelon AC, Hohmann MS, Staurengo-Ferrari L, Ferraz CR, Hayashida TH, de Souza AR, Ambrosio SR, Arakawa NS, Casagrande R, Verri WA Jr.

J Nat Prod. 2014 Nov 26;77(11):2488-96. doi: 10.1021/np500563b. Epub 2014 Nov 13.

PMID:
25394199
44.

Prognostic implications of receptor discordance between primary and recurrent breast cancer.

Matsumoto A, Jinno H, Murata T, Seki T, Takahashi M, Hayashida T, Kameyama K, Kitagawa Y.

Int J Clin Oncol. 2015 Aug;20(4):701-8. doi: 10.1007/s10147-014-0759-2. Epub 2014 Oct 29.

PMID:
25348193
45.

Comparative effectiveness of neoadjuvant therapy for HER2-positive breast cancer: a network meta-analysis.

Nagayama A, Hayashida T, Jinno H, Takahashi M, Seki T, Matsumoto A, Murata T, Ashrafian H, Athanasiou T, Okabayashi K, Kitagawa Y.

J Natl Cancer Inst. 2014 Sep 15;106(9). pii: dju203. doi: 10.1093/jnci/dju203. Print 2014 Sep.

PMID:
25224562
46.

An E2F1-HOXB9 transcriptional circuit is associated with breast cancer progression.

Zhussupova A, Hayashida T, Takahashi M, Miyao K, Okazaki H, Jinno H, Kitagawa Y.

PLoS One. 2014 Aug 19;9(8):e105285. doi: 10.1371/journal.pone.0105285. eCollection 2014.

47.

Selective binding of single-stranded DNA-binding proteins onto DNA molecules adsorbed on single-walled carbon nanotubes.

Nii D, Hayashida T, Yamaguchi Y, Ikawa S, Shibata T, Umemura K.

Colloids Surf B Biointerfaces. 2014 Sep 1;121:325-30. doi: 10.1016/j.colsurfb.2014.06.008. Epub 2014 Jun 10.

PMID:
24974776
48.

Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication.

Hoshino Y, Hayashida T, Hirata A, Takahashi H, Chiba N, Ohmura M, Wakui M, Jinno H, Hasegawa H, Maheswaran S, Suematsu M, Kitagawa Y.

Mol Cancer. 2014 May 5;13:102. doi: 10.1186/1476-4598-13-102.

49.

Low raltegravir concentration in cerebrospinal fluid in patients with ABCG2 genetic variants.

Tsuchiya K, Hayashida T, Hamada A, Kato S, Oka S, Gatanaga H.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):484-6. doi: 10.1097/QAI.0000000000000222.

PMID:
24872134
50.

Loss of B-cell translocation gene 2 expression in estrogen receptor-positive breast cancer predicts tamoxifen resistance.

Takahashi M, Hayashida T, Okazaki H, Miyao K, Jinno H, Kitagawa Y.

Cancer Sci. 2014 Jun;105(6):675-82. doi: 10.1111/cas.12410. Epub 2014 May 2.

Supplemental Content

Loading ...
Support Center